SEC Form 4 · accession 0001078782-16-002911
VOLITIONRX LTD · VNRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cameron John Reynolds
Officer — President and CEO · Director
Period of report
May 20, 2016
Accepted (ET)
May 24, 2016 · 4:57 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000093314
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 20, 2016 | M | 20,000 | $3.00 | A | 1,125,016 | D | |
| Common StockF1 | May 20, 2016 | F | 16,950 | $3.54 | D | 1,108,066 | D | |
| Common Stock | May 20, 2016 | X | 4,000 | $3.00 | A | 32,287 | I | By Wife |
| Common StockF1 | May 20, 2016 | S | 3,390 | $3.54 | D | 28,897 | I | By Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $3.00 | May 20, 2016 | M | 20,000 | D | May 25, 2012 | May 25, 2016 | Common Stock | 20,000 | 0 | D |
| Stock Option (Right to Buy) | $3.00 | May 20, 2016 | X | 4,000 | D | May 25, 2012 | May 25, 2016 | Common Stock | 4,000 | 0 | I |
Explanation of responses
- F1Represents the aggregate amount of shares of VolitionRx Limited Common Stock disposed of in a cashless exercise.